Fate Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2011 | — | — | $6.4M |
| FY2012 | $63.9M | $11.1M | $9.1M |
| FY2013 | $4.7M | $55.6M | $54.0M |
| FY2014 | $22.8M | $51.2M | $49.1M |
| FY2015 | $29.9M | $68.0M | $64.8M |
| FY2016 | $21.9M | $95.0M | $88.6M |
| FY2017 | $28.1M | $105.3M | $89.0M |
| FY2018 | $52.6M | $213.0M | $190.5M |
| FY2019 | $57.5M | $302.3M | $99.8M |
| FY2020 | $238.0M | $622.5M | $167.3M |
| FY2021 | $242.6M | $921.5M | $133.6M |
| FY2022 | $221.6M | $705.6M | $61.3M |
| FY2023 | $137.8M | $506.2M | $41.9M |
| FY2024 | $122.0M | $440.7M | $36.1M |
| FY2025 | $111.8M | $318.9M | $46.6M |